Published by: Frontiers Media S.A.
https://www.frontiersin.org/journals/bioengineering-and-biotechnology
| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Biology and Biochemistry | 64 | 489 | 738 | 51 |
| Engineering and Technology | 161 | 217 | 343 | 35 |
Frontiers in Bioengineering and Biotechnology primarily tackles Cell biology, Biomedical engineering, Chemical engineering, Nanotechnology and Biophysics. The majority of Cell biology studies presented zero in on Mesenchymal stem cell. Biomedical engineering research is the primary subject tackled in Frontiers in Bioengineering and Biotechnology with a focus on Tissue engineering.
The journal publications investigate areas of study like Biotechnology, Tissue engineering, Nanotechnology, Computational biology and Biochemistry. The study on Biotechnology presented in the published papers is investigated in conjunction with research in Biochemical engineering. Scaffold, Regenerative medicine, Regeneration (biology) and Bioinformatics are some topics wherein Tissue engineering research discussed in the most cited articles has an impact.
Frontiers in Bioengineering and Biotechnology explores disciplines such as Cell biology, Biomedical engineering, Biochemistry, Tissue engineering and Nanotechnology. The in-depth study on Cell biology also explores topics in the intersecting field of Cell. Biosynthesis is a key component of Biochemistry research discussed in Frontiers in Bioengineering and Biotechnology.
Scaffold, Extracellular matrix and Regeneration (biology) are some topics wherein Tissue engineering research discussed in the journal have an impact.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Frontiers in Bioengineering and Biotechnology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Frontiers in Bioengineering and Biotechnology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 8.15% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 13.73% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.91% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.14% of all publications and 65.22% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
One section that is noticeably absent from this article on Frontiers in Bioengineering and Biotechnology is an exploration of emerging fields and novel research directions within these specified areas. Including this section would provide readers with a forward-thinking perspective about the dynamic evolution of bioengineering and biotechnology studies. Diversified developments and interdisciplinary collaboration form the bedrock of growth within Bioengineering and Biotechnology. Several emerging areas hold promise for breakthrough research impact. Novel research avenues are opening up in areas like synthetic biology which leverages engineering principles for designing, building, and testing new biological parts and systems. Further advances in Bioinformatics hold the key to decoding complex biological datasets more efficiently.
Another promising area lies in Biomedical engineering where topics like telemedicine and wearable technology are taking center stage. The increasing intersection of fields like Computer Science with traditional Biotechnology is paving the way for development of smart healthcare solutions. Know how to apply these interdisciplinary principles effectively with our helpful guide on how to become a medical coder in South Dakota.
Lastly, we also witness novel research directions in Environmental Biotechnology for sustainable energy production and ecosystems management, further highlighting the potential of Bioengineering and Biotechnology in addressing real-world problems. Keep an eye on our journal to stay updated on these fascinating developments.
Gulshan Kumar;Ajam Shekh;Sunaina Jakhu;Yogesh Sharma
(2020)Esmaeil Shahsavari;Duncan Rouch;Leadin S. Khudur;Duncan Thomas
(2021)Ariane Théatre;Carolina Cano-Prieto;Marco Bartolini;Yoann Laurin
(2021)Ian Holland;Jamie A Davies
(2020)Mario Gomez-Salazar;Zaniah N. Gonzalez-Galofre;Joan Casamitjana;Mihaela Crisan
(2020)Marie Maumus;Pauline Rozier;Jérémy Boulestreau;Christian Jorgensen
(2020)Zeynep Busra Bolat;Zeynep Islek;Bilun Nas Demir;Elif Nur Yilmaz
(2020)For students studying Chemistry in the USA, exploring related online degrees can open up diverse career opportunities. Many aspiring professionals consider pursuing an online pharmd to deepen their expertise in pharmaceutical sciences while maintaining flexibility with their schedules.
Additionally, those currently working in healthcare, such as registered nurses, might find easiest rn to bsn online program options helpful for advancing their qualifications without interrupting their careers.
For students eager to accelerate their path, accelerated pharm d programs offer intensive curriculums that shorten the time to degree completion, ideal for those motivated to enter the workforce sooner.
Career-wise, chemistry graduates with a pharmaceutical background often pursue roles such as a pharmaceutical sales representative. Understanding the pharmaceutical rep salary and career pathways can help set realistic expectations and career goals in this competitive field.
INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
Publications: 6